We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
News

Colon Cancer Cells Use RNA Strands to Evade Cell Death

Rectangle Image
News

Colon Cancer Cells Use RNA Strands to Evade Cell Death

Colon Cancer Cells. Credit: Urbain Weyemi, Christophe E. Redon, William M. Bonner. NCI
Read time:
 

Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth. Unlike other RNAs, the intriguing strands do not appear to encode proteins and are termed “long non-coding RNAs” or “lincRNAs.”A new study showed some lincRNAs could be targeted by drug developers to halt colon cancer.

In a new study published in Scientific Reports, researchers compared lincRNA levels inside tumor cells, to levels inside healthy colon cells. They found over 200 lincRNAs at significantly different levels inside the tumor cells as compared to normal cells. One in particular, called lincDUSP, was overexpressed in 91 percent of the tumor samples. A few tumors had more than fifteen times the normal amount of lincDUSP. The significant increase suggested this mysterious, and previously uncharacterized, RNA could be cancer-causing.

“To determine whether lincDUSP shows oncogenic activity in colon cancer, we decided to test the effects of depleting lincDUSP in patient-derived colon tumor cell lines,” wrote the authors. The researchers genetically modified colon cancer cells to deplete lincDUSP, and surprisingly, the cells began replicating at normal rates. They no longer had unrestricted growth associated with colon cancer tumor cells. Small molecules that inhibit lincDUSP, say the researchers, could have similar effects.

“Our work demonstrates that not only protein-coding genes but also non-coding genes contribute to colon cancer progression,” says Ahmad Khalil, PhD, senior author, assistant professor of genetics and genome sciences at Case Western Reserve University School of Medicine, and member of the Case Comprehensive Cancer Center. “LincRNAs could be exploited as direct drug targets in this and other human diseases.”

Khalil’s team discovered that depleting lincDUSP restored inherent cell death mechanisms. Colon cancer cells with low levels of lincDUSP became susceptible to cellular checkpoints that keep growth in check. They immediately committed cell suicide—apoptosis—at the first sign of DNA damage. Depleting the single lincRNA also had widespread genetic effects. Khalil’s team discovered that reducing lincDUSP levels affected expression of over 800 other genes. These results, combined with the team’s experiments showing lincDUSP interacting with DNA, add to a growing body of evidence that lincRNAs are central to gene regulation. As such, they could represent an intriguing arena for drug developers.

“Not much is known about the role of long non-coding RNAs in colon cancer,” says Khalil. “Using new technologies that target RNA molecules, instead of proteins, adds a new dimension to cancer therapies.”

This article has been republished from materials provided by Case Western Reserve University. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement